Gilead, Precision to co-develop hepatitis B therapies

13th September 2018 Uncategorised 0

Gilead and Precision BioSciences are to work together on developing gene-editing treatments against hepatitis B.

More: Gilead, Precision to co-develop hepatitis B therapies
Source: News